AHC & ATP1A3 10 Year Conference & Symposium: RESEARCHERS/CLINICIANS TICKETS

AHC & ATP1A3 10 Year Conference & Symposium: RESEARCHERS/CLINICIANS TICKETS

Actions and Detail Panel

£100 – £215

Date and time

Location

Royal College of Physicians of Edinburgh

11 Queen Street

Edinburgh

EH2 1JQ

United Kingdom

View map

Refund policy

Contact the organizer to request a refund.

Eventbrite's fee is nonrefundable.

10 years since the ATP1A3 gene discovery, this hybrid event highlights the progress to date and future research for AHC and ATP1A3 diseases

About this event

This link is for bookings for Researchers and Clinicians ONLY

(family bookings will be distributed separately in June via patient organisations. If you have not received this please contact support@ahcuk.org)

The full programme for the event will be released shortly (a summary/taster can be found below)

This is a HYBRID EVENT - please select the correct ticket for the Venue (Face-to-Face) or Online

----------------------

‘DEFINING THE FUTURE FOR AHC & ATP1A3 DISEASES’

------------------------

A 3 DAY UNIQUE EVENT INCORPORATING:

• 10-year anniversary conference commemorating the discovery of the ATP1A3 gene in AHC and ATP1A3 diseases

• The 10th Symposium on ATP1A3 in disease

This 3 Day unique event will be focused on those most impacted by research outcomes; with an opportunity to learn from their experiences and their priorities for future research to improve the research landscape and clinical care.

It will also include an overview of the last 10 years since the gene discovery, alongside current and future research plans for AHC and ATP1A3 Diseases.

-----------------------------

Where? – Hybrid event - EDINBURGH and ONLINE

Face-toFace VENUE:

Conference Centre, The Royal College of Physicians of Edinburgh,

9 Queens Street, Edinburgh, EH2 1JQ

When? - 19th-21st October 2022

The conference will run from Wednesday-Friday (programme to be released shortly), with an evening formal dinner for delegates and speakers on Thursday 20th October (Great Hall, The Royal College of Physicians of Edinburgh)

--------------------

BRINGING TOGETHER PEOPLE WITH LIVED EXPERIENCE OF

AHC AND ATP1A3 DISEASES, RESEARCHERS AND CLINICIANS

-------------------

To submit an oral or poster presentation, please email: support@ahcuk.org by 31st August 2022. All submissions must use accessible language and style. Prizes for best oral and poster presentation.

--------------------

The co-applicants and organising committee of the 10-year conference and 10th Symposium on ATP1A3 in disease are grateful for the generous grant from the European Joint Programme on Rare Diseases to support this event.

---------------

AHC & ATP1A3 10 Year Conference & Symposium: RESEARCHERS/CLINICIANS TICKETS image
AHC & ATP1A3 10 Year Conference & Symposium: RESEARCHERS/CLINICIANS TICKETS image

The Past, Present, Future

The past 10 years, the present knowledge and defining the future priorities for Alternating Hemiplegia of Childhood (AHC) and ATP1A3 diseases

This unique event will be a journey of discovery in Alternating Hemiplegia of Childhood (AHC) and ATP1A3 diseases since the gene discovery 10 years ago………Where have we come from, where have we reached, and what is next?

It will incorporate the 10-year anniversary conference of AHC & ATP1A3 diseases and the 10th Symposium on ATP1A3 in disease.

Sessions will cover:

• AHC and ATP1A3 diseases – where are we now and where are we going?• Collaborative science – the ATP1A3 community and what it has brought

• Sharing current research on AHC and ATP1A3 diseases: the life-course clinical perspective

• Key dilemmas for clinicians, researchers, and families

• Back to the lab – the latest updates on AHC & ATP1A3 diseases advances in research

• Driving forward research and understanding in rare diseases: how can patients and families be involved in research?

• Driving forward knowledge in AHC and ATP1A3 diseases: how can learning from patients and families improve clinical care?

• Moving forwards with research: clinical trials

• Moving forwards with research: gene therapy strategies

More information on all the sessions will be released in the coming weeks with the full programme

Keynote plenary speaker

In recognition of the 10- year anniversary since the ATP1A3 gene discovery for AHC and ATP1A3 diseases, we are delighted to announce:

Professor Kathleen Sweadner

'ATP1A3 disease –phenotypic description to gene discovery’

Plenary talk discussing the basic science perspective of the gene discovery

The full programme, speakers and all presentations will be released shortly Here is a taster, including presentations and discussion on (more topics and information to follow):

  • Future research priorities for families (and those with the lived experience of the diseases) and researchers/clinicians
  • Addressing the genotype-phenotype correlation in AHC and ATP1A3 diseases
  • ATP1A3 mutations cause polymicrogyria
  • Transition from childhood to adulthood
  • AHC – a lifelong disease. Long term follow-up of adults with AHC
  • Sleep issues in AHC and ATP1A3 diseases
  • Updates from TREAT AHC research study– What drugs are being tried?
  • ATP1A3 expression: spinal cord/motor function
  • Patient-driven registries
  • How to engage patients for faster transfer of research results to clinical practice
  • Preparing for clinical trials in AHC and ATP1A3 diseases
  • Updates in gene therapy research for AHC & ATP1A3 diseases

#10yearsATP1A3

Share with friends